Error: Could not add to watchlist. X

Caladrius Biosciences Inc

+ Watchlist
NBS:US
Ticker Change
NBS:US has changed to a new ticker symbol
2.25
USD
0.00
0.00%
As of 20:10:00 ET on 06/05/2015.
Volume
1,117,631
Previous Close
2.25
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Caladrius Biosciences, Inc. is an immunotherapy company that specializes in cell process optimization, development, and manufacturing. The Company engages in late-stage clinical programs, utilizing platform technologies for ischemic repair and immunomodulation. Caladrius operates in the United States.
ADDRESS
420 Lexington Avenue
Suite 350
New York, NY 10170
United States
PHONE
1-212-584-4180
  • Robin L Smith
    Chairman
  • David J Mazzo
    Chief Executive Officer
  • Robert S Vaters
    President/CFO/Secretary
  • Andrew L Pecora
    Chief Visionary Officer
  • Douglas W Losordo
    Chief Medical Officer
Show More